Tumor-associated antigen 90K activates myelomonocytic cell line THP-1

被引:15
作者
Altindag, ZZ
Marth, C
WernerFelmayer, G
Natoli, C
Zeimet, AG
Wachter, H
Iacobelli, S
Fuchs, D
机构
[1] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, A-6020 INNSBRUCK, AUSTRIA
[2] UNIV INNSBRUCK, LUDWIG BOLTZMANN INST AIDS RES, A-6020 INNSBRUCK, AUSTRIA
[3] UNIV INNSBRUCK, DEPT OBSTET & GYNECOL, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV G DANNUNZIO, CATTEDRA ONCOL MED, CHIETI, ITALY
关键词
90K; interferon-gamma; neopterin formation; tryptophan degradation; monocytes;
D O I
10.1016/0304-3835(96)04364-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
90K is a tumor-associated antigen. Using myelomonocytic cell line THP-1 we determined neopterin production and tryptophan degradation after exposure of cells to 90K in the presence and the absence of interferon-gamma. Interferon-gamma is a well known stimulus for THP-1 cells inducing e.g. neopterin production and tryptophan degradation. Treatment of cells with 50 mu g/ml 90K induced significant neopterin formation, and the exposure of cells to 90K in addition to 100 U/ml interferon-gamma amplified neopterin production compared to the sole effect of interferon-gamma. In parallel, a significant degradation of tryptophan was observed in culture supematants leading to the formation of kynurenine. When the cells were treated with the combination of 90K and interferon-gamma the degradation of tryptophan was further enhanced. The data demonstrate that tumor-associated antigen 90K interferes with immunocompetent target cells and is able to induce a biochemical response in monocytic cells.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 26 条
[1]   REMOVAL OF ENDOTOXIN FROM PROTEIN SOLUTIONS BY PHASE-SEPARATION USING TRITON X-114 [J].
AIDA, Y ;
PABST, MJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (02) :191-195
[2]  
BERCHTOLD C, 1995, CANC LETT, V94, P227
[3]   SELECTIVE INDUCTION OF MONONUCLEAR PHAGOCYTES TO PRODUCE NEOPTERIN BY INTERFERONS [J].
BITTERLICH, G ;
SZABO, G ;
WERNER, ER ;
LARCHER, C ;
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
SCHULZ, TF ;
TROPPMAIR, J ;
WACHTER, H ;
DIERICH, MP .
IMMUNOBIOLOGY, 1988, 176 (03) :228-235
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN [J].
BRIGGS, NC ;
NATOLI, C ;
TINARI, N ;
DEGIDIO, M ;
GOEDERT, JJ ;
IACOBELLI, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) :811-816
[6]   WEIGHT-LOSS IN PATIENTS WITH HEMATOLOGICAL NEOPLASIAS IS ASSOCIATED WITH IMMUNE-SYSTEM STIMULATION [J].
DENZ, H ;
ORTH, B ;
WEISS, G ;
HERRMANN, R ;
HUBER, P ;
WACHTER, H ;
FUCHS, D .
CLINICAL INVESTIGATOR, 1993, 71 (01) :37-41
[7]  
FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873
[8]  
GASSE T, 1994, EUR J CLIN CHEM CLIN, V32, P685
[9]   IMMUNE-RESPONSE ASSOCIATED PRODUCTION OF NEOPTERIN - RELEASE FROM MACROPHAGES PRIMARILY UNDER CONTROL OF INTERFERON-GAMMA [J].
HUBER, C ;
BATCHELOR, JR ;
FUCHS, D ;
HAUSEN, A ;
LANG, A ;
NIEDERWIESER, D ;
REIBNEGGER, G ;
SWETLY, P ;
TROPPMAIR, J ;
WACHTER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :310-316
[10]   PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER [J].
IACOBELLI, S ;
SISMONDI, P ;
GIAI, M ;
DEGIDIO, M ;
TINARI, N ;
AMATETTI, C ;
DISTEFANO, P ;
NATOLI, C .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :172-176